I/O in Lung Cancer - 6: Analyst Says US Merck Claimed Victory in 2018 ASCO Confab, Applauds Trial Designs for Keytruda

Atsushi Seki, Executive Director, UBS Investment Research, Analyst, Japan Pharmaceuticals Sector, Equities Research, Global Research Division, UBS Securities Japan By Takashi Ebisawa This year’s American Society of Clinical Oncology (ASCO) conference virtually marked a resounding victory for US Merck, with...read more